The enlightenment of the design of original drug medical insurance payment standard system in typical countries and regions for China
10.3969/j.issn.1674-2982.2024.08.009
- VernacularTitle:典型国家和地区原研药医保支付标准设计对我国的启示
- Author:
Lei REN
1
;
Jin-Ping XIE
;
Yi-Fan YANG
;
Rong SHAO
Author Information
1. 中国药科大学国家药物政策与医药产业经济研究中心 江苏南京 211198
- Keywords:
National centralized drug procurement;
Medical insurance payment standard;
Original drug;
Drug price
- From:
Chinese Journal of Health Policy
2024;17(8):65-71
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To provide reference for the management of drug medical insurance payment standard under the background of the national drug centralized procurement policy.Method:Research on the management experience of drug and medical insurance payment standard in typical countries and regions.Result:There is a relatively complete drug medical insurance payment standard management system in the typical countries and regions of studied,refer to multiple factors such as the actual trading price in the market,and there are differences in drug medical insurance payment standard between generic and original drug.Recommendation:It is recommended to improve relevant policy documents,and establish a scientific management system for drug medical insurance payment standards,establish a market-oriented mechanism for forming drug medical insurance payment standards through drug market price transactions,and refine classification management based on different attributes of different drugs such as generic drugs and original drugs.At the same time,under the current policy of implementing the same drug medical insurance payment standard for drugs with the same generic name of national drug centralized procurement,it is recommended to continue promoting and optimizing the consistency evaluation of generic drugs,achieving consistency in clinical efficacy between generic drugs and original drugs,in line with the current policy orientation of implementing the same drug medical insurance payment standard for generic drugs and original drugs.
